Back GBD 2019 Risk Factor Collaborators (2020) 'Global Burden of 87 Risk Factors in 204 Countries and Territories, 19902019: a systematic analysis for the global burden of disease study 2019', The Lancet , 396, 122349
Understanding your genetic and hormonal context can support a more informed conversation with your provider about GLP-1 treatment during menopause
International status Banned for human-use sale in the UK and Australia
Many commercial plans cover GLP-1 receptor agonists for type 2 diabetes, but chronic weight-management coverage varies widely, is often BMI-gated, and is sometimes excluded
In practical terms, patients use a small subcutaneous dose ahead of intimacy to heighten interest and responsiveness
What to Do About Carbs and Fats on a GLP-1 Protein is the priority